Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast Cancer

NCT01194869 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

25

Enrollment

OTHER

Sponsor class

Stopped Slow accrual, availability of other clinical options

Conditions

Breast Cancer

Interventions

DRUG: Sorafenib
DRUG: Cisplatin
DRUG: Paclitaxel

Sponsor

Emory University

Collaborators

[object Object]
[object Object]